Application of Ultra-High Throughput Sequencing and Microarray Technologies in Pharmacogenomics Testing

Therapeutic Drug Monitoring

Volumn , Issue , 2012, Pages 143-159

  Hardiman, Gary ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882491131     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-385467-4.00007-5     Document Type: Chapter

References (49)

1. Marton M.J., DeRisi J.L., Bennett H.A., et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nature Med 1998, 4:1293-1301.
2. Brown P.O., Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 1999, 21:33-37.
3. Hardiman G., Carmen A. DNA biochips - past, present and future; an overview. Biochips as Pathways to Discovery 2006, 1-13. Taylor & Francis, New York, NY. A. Carmen, G. Hardiman (Eds.).
4. Hardiman G. Microarray platforms - comparisons and contrasts. Pharmacogenomics 2004, 5:487-502.
5. Chee M., Yang R., Hubbell E., et al. Accessing genetic information with high-density DNA arrays. Science 1996, 274:610-614.
6. Lipshutz R.J., Fodor S.P.A., Gingeras T.R., Lockhart D.J. High density synthetic oligonucleotide arrays. Nat Gen Suppl 1999, 21:20-24.
7. Hughes T.R., Mao M., Jones A.R., et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 2001, 19:342-347.
8. Mardis E.R. The impact of next-generation sequencing technology on genetics. Trends Genet 2008, 24:133-141.
9. Margulies M., Egholm M., Altman W.E., et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005, 437:376-380.
10. Shendure J., Mitra R.D., Varma C., Church G.M. Advanced sequencing technologies: methods and goals. Nat Rev Genet 2004, 5:335-344.
11. Vilo J., Kivinen K. Regulatory sequence analysis: application to the interpretation of gene expression. Eur Neuropsychopharmacol 2001, 11:399-411.
12. Waring J.F., Ciurlionis R., Jolly R.A., et al. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 2001, 120:359-368.
13. Hamadeh H.K., Amin R.P., Paules R.S., Afshari C.A. An overview of toxicogenomics. Curr Issues Mol Biol 2002, 4:45-56.
14. Johnson J.A. Drug target pharmacogenomics: an overview. Am J Pharmacogenomics 2001, 1:271-281.
15. Kruglyak L., Nickerson D.A. Variation is the spice of life. Nat Genet 2001, 27:234-236.
16. Evans W.E., Relling M.V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999, 286:487-491.
17. Bhasker C.R., Hardiman G. Advances in pharmacogenomics technologies. Pharmacogenomics 2010, 11:481-485.
18. Ensom M.H., Chang T.K., Patel P. Pharmacogenetics: the therapeutic drug monitoring of the future?. Clin Pharmacokinet 2001, 40:783-802.
19. Collins F.S. Medical and societal consequences of the Human Genome Project. N Engl J Med 1999, 341:28.
20. Kleyn P.W., Vesell E.S. Genetic variation as a guide to drug development. Science 1998, 281:1820.
21. PricewaterhouseCoopers' Health Research Institute The new science of personalized medicine 2009, Available at. http://www.pwc.com/personalizedmedicine.
22. Hardiman G. Applications of microarrays and biochips in pharmacogenomics. Methods Mol Biol 2008, 448:21-30.
23. Lundkvist J., Jönsson B. Pharmacoeconomics of adverse drug reactions. Fund Clin Pharmacol 2004, 18:275-280.
24. Amur S., Zineh I., Abernethy D.R., et al. Pharmacogenomics and adverse drug reactions. Personal Med 2010, 7:633-642.
25. Routledge P.A., O'Mahony M.S., Woodhouse K.W. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004, 57:121-126.
26. Nuwaysir E.F., Huang W., Albert T.J., et al. Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res 2002, 12:1749-1755.
27. Ramakrishnan R., Dorris D., Lublinsky A., et al. An assessment of Motorola CodeLink™ microarray performance for gene expression profiling applications. Nucleic Acids Res 2002, 30:e30.
28. Gunderson K.L., Kuhn K.M., Steemers F.J., et al. Whole-genome genotyping of haplotype tag single nucleotide polymorphisms. Pharmacogenomics 2006, 7:641-648.
29. Steemers F.J., Chang W., Lee G., et al. Whole-genome genotyping with the single-base extension assay. Nat Methods 2006, 3:31-33.
30. The International HapMap Consortium A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-862.
31. Stankiewicz P., Lupski J.R. Structural variation in the human genome and its role in disease. Annu Rev Med 2010, 61:437-455.
32. Mahant V., Kureshy F., Vairavan R., Hardiman G. The INFINITI system - an automated multiplexing microarray platform. Microarray Methods and Applications 2003, 325-328. DNA Press Inc., Eagleville, PA. G. Hardiman (Ed.).
33. Kim P., Fu Y.K.K., Mahant V., et al. The next generation of automated microarray platform for a multiplexed CYP2D6 assay. Biochips as Pathways to Discovery 2006, 97-108. Taylor & Francis, New York, NY. A. Carmen, G. Hardiman (Eds.).
34. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977, 74:5463-5467.
35. Sanger F., Coulson A.R. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 1975, 94:441-448.
36. Sanger F., Air G.M., Barrell B.G., et al. Nucleotide sequence of bacteriophage phi X174 DNA. Nature 1977, 265:687-695.
37. Maxam A.M., Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci USA 1977, 74:560-564.
38. Rogers Y.H., Venter J.C. Genomics: massively parallel sequencing. Nature 2005, 437:326-327.
39. Margulies M., Egholm M., Altman W.E., et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005, 437:376-380.
40. Wheeler D.A., Srinivasan M., Egholm M., et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 2008, 452:872-876.
41. Korbel J.O., Urban A.E., Affourtit J.P., et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007, 318:420-426.
42. Shendure J., Mitra R.D., Varma C., Church G.M. Advanced sequencing technologies: methods and goals. Nat Rev Genet 2004, 5:335-344.
43. Johnson D.S., Mortazavi A., Myers R.M., Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316:1497-1502.
44. Barski A., Cuddapah S., Cui K., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
45. Winters-Hilt S., Vercoutere W., DeGuzman V.S., et al. Highly accurate classification of Watson-Crick basepairs on termini of single DNA molecules. Biophys J 2003, 84:967-976.
46. Okou D.T., Steinberg K.M., Middle C., et al. Microarray-based genomic selection for high-throughput resequencing. Nat Methods 2007, 11:907-909.
47. Hodges E., Xuan Z., Balija V., et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet 2007, 39:1522-1527.
48. Albert T.J., Molla M.N., Muzny D.M., et al. Direct selection of human genomic loci by microarray hybridization. Nat Methods 2007, 11:903-905.
49. Porreca G.J., Zhang K., Li J.B., et al. Multiplex amplification of large sets of human exons. Nat Methods 2007, 11:931-936.